journal article·2024-02-10Open access

Superfluorinated, Highly Water-Soluble Polyphosphazenes as Potential 19F Magnetic Resonance Imaging (MRI) Contrast Agents

Paul Strasser, Verena Schinegger, Joachim Friske, Oliver Brüggemann, Thomas H. Helbich, Ian Teasdale, Irena Pashkunova-Martic

Abstract

“Hot spot” 19F magnetic resonance imaging (MRI) has garnered significant attention recently for its ability to image various disease markers quantitatively. Unlike conventional gadolinium-based MRI contrast agents, which rely on proton signal modulation, 19F-MRI’s direct detection has a unique advantage in vivo, as the human body exhibits a negligible background 19F-signal. However, existing perfluorocarbon (PFC) or PFC-based contrast materials suffer from several limitations, including low longitudinal relaxation rates and relatively low imaging efficiency. Hence, we designed a macromolecular contrast agent featuring a high number of magnetically equivalent 19F-nuclei in a single macromolecule, adequate fluorine nucleus mobility, and excellent water solubility. This design utilizes superfluorinated polyphosphazene (PPz) polymers as the 19F-source; these are modified with sodium mercaptoethanesulfonate (MESNa) to achieve water solubility exceeding 360 mg/mL, which is a similar solubility to that of sodium chloride. We observed substantial signal enhancement in MRI with these novel macromolecular carriers compared to non-enhanced surroundings and aqueous trifluoroacetic acid (TFA) used as a positive control. In conclusion, these novel water-soluble macromolecular carriers represent a promising platform for future MRI contrast agents.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Lanthanide and Transition Metal Complexes · Advanced MRI Techniques and Applications · Magnetism in coordination complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute of Polymer Chemistry, Johannes Kepler University Linz, Altenberger Straße 69, 4040 Linz, Austria

Department of Biomedical Imaging and Image-Guided Therapy, Division of Structural and Molecular Preclinical Imaging, Medical University of Vienna and General Hospital of Vienna, 18-20 Währinger Gürtel, 1090 Vienna, Austria

Funding

Austrian Science Fund

References (40)

Show source-provided references
1. Notes on “Characteristics of Gadolinium-DTPA Complex: A Potential NMR Contrast Agent”10.2214/AJR.07.3549 ↗
2. Gries, H., Rosenberg, D., and Weinmann, H.J. (1987). Paramagnetic complex salts, their preparation, and their use in NMR-diagnostics. (ZA825313B).
3. Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent10.2214/ajr.142.3.619 ↗
4. Evaluation of contrast-enhanced MR imaging in a brain-abscess model
5. Top 100 Cited AJR Articles at the AJR’s Centennial10.2214/AJR.05.1186 ↗
6. First use of GdDTPA/dimeglumine in man
7. Pharmacokinetics of GdDTPA/dimeglumine after intravenous injection into healthy volunteers
8. 25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives10.1007/s12325-015-0275-4 ↗
9. Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers10.1021/acs.chemrev.8b00363 ↗
10. Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists10.1177/2054358118778573 ↗
11. Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: Literature review10.1016/j.ejro.2023.100503 ↗
12. Critical Questions Regarding Gadolinium Deposition in the Brain and Body After Injections of the Gadolinium-Based Contrast Agents, Safety, and Clinical Recommendations in Consideration of the EMA’s Pharmacovigilance and Risk Assessment Committee Recommendation for Suspension of the Marketing Authorizations for 4 Linear Agents10.1097/RLI.0000000000000374 ↗
13. Recent Research Progress of 19 F Magnetic Resonance Imaging Probes: Principle, Design, and Their Application10.1002/marc.202200744 ↗
14. Recent Advances in 19Fluorine Magnetic Resonance Imaging with Perfluorocarbon Emulsions10.15302/J-ENG-2015103 ↗
15. Perfluorocarbon Nanoparticles: Evolution of a Multimodality and Multifunctional Imaging Agent10.1155/2014/746574 ↗
16. Prognostic Value of Fluorine-19 MRI Oximetry Monitoring in cancer10.1007/s11307-021-01648-3 ↗
17. 19 F MRI in orthotopic cancer model via intratracheal administration of α ν β 3 -targeted perfluorocarbon nanoparticles10.2217/nnm-2018-0051 ↗
18. Fluorine MR Imaging Probes Dynamic Migratory Profiles of Perfluorocarbon-Loaded Dendritic Cells After Streptozotocin-Induced Inflammation10.1007/s11307-021-01701-1 ↗
19. Polymeric 19 F MRI Contrast Agents Prepared by Ring-Opening Metathesis Polymerization/Dihydroxylation10.1021/acs.macromol.0c01585 ↗
20. Low-Fouling Fluoropolymers for Bioconjugation and In Vivo Tracking10.1002/anie.201914119 ↗
21. Partially Fluorinated Copolymers as Oxygen Sensitive 19 F MRI Agents10.1002/chem.202001505 ↗
22. Preparation of polyphosphazenes: A tutorial review10.1039/C6CS00340K ↗
23. The expanding field of polyphosphazene high polymers10.1039/C5DT03887A ↗
24. Strasser, P., and Teasdale, I. (2020). Main-Chain Phosphorus-Containing Polymers for Therapeutic Applications. Molecules, 25.10.3390/molecules25071716 ↗
25. Alexander, A.K. (2006). Vaccine Adjuvants and Delivery Systems, John Wiley & Sons, Ltd.
26. Chain-End-Functionalized Polyphosphazenes via a One-Pot Phosphine-Mediated Living Polymerization10.1002/marc.201400114 ↗
27. Hetero and homo α,ω-chain-end functionalized polyphosphazenes10.1002/pol.20220066 ↗
28. Translational Research and Early Favorable Clinical Results of a Novel Polyphosphazene (Polyzene-F) Nanocoating10.1007/s40883-019-00097-3 ↗
29. Recent Advances in Polymer Drug Conjugates10.2174/1389557515666150519104507 ↗
30. Polyphosphazene: A New Adjuvant Platform for Cocaine Vaccine Development10.1021/acs.molpharmaceut.2c00489 ↗
31. Degradable Bottlebrush Polypeptides and the Impact of their Architecture on Cell Uptake, Pharmacokinetics, and Biodistribution In Vivo10.1002/smll.202300767 ↗
32. A New High-Yield Synthesis of Cl3PNSiMe3, a Monomeric Precursor for the Controlled Preparation of High Molecular Weight Polyphosphazenes10.1021/ic011125n ↗
33. Polyphosphazene Elastomers with Alkoxy and Trifluoroethoxy Side Groups10.1021/acsapm.9b00913 ↗
34. Application of 19 F NMR Spectroscopy for Content Determination of Fluorinated Pharmaceuticals10.1155/2017/9206297 ↗
35. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths10.1097/01.rli.0000184756.66360.d3 ↗
36. The protein and contrast agent-specific influence of pathological plasma-protein concentration levels on contrast-enhanced magnetic resonance imaging10.1097/RLI.0000000000000061 ↗
37. A Superfluorinated Molecular Probe for Highly Sensitive in Vivo19 F-MRI10.1021/ja503270n ↗
38. Optimization of rapid acquisition with relaxation enhancement (RARE) pulse sequence parameters for ¹⁹F-MRI studies10.1002/jmri.24347 ↗
39. Characterization of perfluorocarbon relaxation times and their influence on the optimization of fluorine-19 MRI at 3 tesla10.1002/mrm.26317 ↗
40. Fluorine polymer probes for magnetic resonance imaging: Quo vadis?10.1007/s10334-018-0724-6 ↗